Position in CGC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,146
-$5,415 QoQ
Shares Held
15,944
-26.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 212 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $48,172,745 across 31 Drug Manufacturers - Specialty & Generic names. CGC ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
419,136 | $6,655,879 | |
| 2 | ZTS |
Zoetis Inc.
|
81,282 | $5,840,924 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,944 | $4,846,127 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
26,150 | $4,407,321 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
120,099 | $4,163,832 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
122,056 | $3,003,798 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,581 | $2,899,484 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
152,601 | $2,446,194 |
All Filings in CGC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,146 | 15,944 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,561 | 21,666 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $21,289 | 18,675 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,097 | 26,779 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $37,860 | 31,033 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $45,804 | 50,335 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $114,137 | 41,656 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $322,048 | 66,815 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $365,160 | 56,614 | Shares | Sole | 2024-08-22 | |
| 2023-12-31 | $58,018 | 11,354 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $54,186 | 69,204 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $25,130 | 14,360 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $33,508 | 14,506 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $34,286 | 12,559 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,591 | 12,839 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $98,706 | 13,022 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $108,863 | 12,470 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $139,195 | 10,043 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $222,190 | 9,189 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $294,708 | 9,201 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||